505 related articles for article (PubMed ID: 11335753)
1. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry.
Wajnrajch MP; Gertner JM; Huma Z; Popovic J; Lin K; Verlander PC; Batish SD; Giampietro PF; Davis JG; New MI; Auerbach AD
Pediatrics; 2001 Apr; 107(4):744-54. PubMed ID: 11335753
[TBL] [Abstract][Full Text] [Related]
2. Endocrine abnormalities in patients with Fanconi anemia.
Giri N; Batista DL; Alter BP; Stratakis CA
J Clin Endocrinol Metab; 2007 Jul; 92(7):2624-31. PubMed ID: 17426088
[TBL] [Abstract][Full Text] [Related]
3. Small pituitary size in children with Fanconi anemia.
Sherafat-Kazemzadeh R; Mehta SN; Care MM; Kim MO; Williams DA; Rose SR;
Pediatr Blood Cancer; 2007 Aug; 49(2):166-70. PubMed ID: 17274008
[TBL] [Abstract][Full Text] [Related]
4. Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation.
Dillon B; Feben C; Segal D; du Plessis J; Reynders D; Wainwright R; Poole J; Krause A
Mol Genet Genomic Med; 2020 Aug; 8(8):e1351. PubMed ID: 32529760
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin and growth hormone serum levels during the clonidine test in children with short stature and variable growth hormone status.
Stylianou C; Galli-Tsinopoulou A; Grammatikopoulou MG; Koliakos G; Varlamis G
Hormones (Athens); 2011; 10(1):39-45. PubMed ID: 21349805
[TBL] [Abstract][Full Text] [Related]
6. Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation.
Barnum JL; Petryk A; Zhang L; DeFor TE; Baker KS; Steinberger J; Nathan B; Wagner JE; MacMillan ML
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1487-1492. PubMed ID: 27180116
[TBL] [Abstract][Full Text] [Related]
7. Empty sella in short children with and without hypothalamic-pituitary abnormalities.
Soliman AT; Darwish A; Asfour MG
Indian J Pediatr; 1995; 62(5):597-603. PubMed ID: 10829929
[TBL] [Abstract][Full Text] [Related]
8. Fanconi Anemia and Laron Syndrome.
Castilla-Cortazar I; de Ita JR; Aguirre GA; Castorena-Torres F; Ortiz-Urbina J; García-Magariño M; de la Garza RG; Diaz Olachea C; Elizondo Leal MI
Am J Med Sci; 2017 May; 353(5):425-432. PubMed ID: 28502327
[TBL] [Abstract][Full Text] [Related]
9. Growth and management of short stature in thalassaemia major.
Theodoridis C; Ladis V; Papatheodorou A; Berdousi H; Palamidou F; Evagelopoulou C; Athanassaki K; Konstantoura O; Kattamis C
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():835-44. PubMed ID: 10091154
[TBL] [Abstract][Full Text] [Related]
10. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh.
Maheshwari HG; Silverman BL; Dupuis J; Baumann G
J Clin Endocrinol Metab; 1998 Nov; 83(11):4065-74. PubMed ID: 9814493
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone secretory pattern and response to treatment in children with short stature followed to adult height.
Radetti G; Buzi F; Cassar W; Paganini C; Stacul E; Maghnie M
Clin Endocrinol (Oxf); 2003 Jul; 59(1):27-33. PubMed ID: 12807500
[TBL] [Abstract][Full Text] [Related]
12. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
[TBL] [Abstract][Full Text] [Related]
13. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
14. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
[TBL] [Abstract][Full Text] [Related]
15. Functional and total IGFBP3 for the assessment of disorders of the GH/IGF1 axis in children with chronic kidney disease, GH deficiency, or short stature after SGA status at birth.
Büscher AK; Büscher R; Pridzun L; Langkamp M; Wachendorfer N; Hoyer PF; Ranke MB; Hauffa BP
Eur J Endocrinol; 2012 May; 166(5):923-31. PubMed ID: 22318747
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment: Retesting early in the course of GH treatment.
Vuralli D; Gonc EN; Ozon ZA; Alikasifoglu A; Kandemir N
Growth Horm IGF Res; 2017 Jun; 34():31-37. PubMed ID: 28511077
[TBL] [Abstract][Full Text] [Related]
17. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion.
Roth C; Pekrun A; Bartz M; Jarry H; Eber S; Lakomek M; Schröter W
Eur J Pediatr; 1997 Oct; 156(10):777-83. PubMed ID: 9365067
[TBL] [Abstract][Full Text] [Related]
18. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
19. Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy.
Sharma R; Seth A; Chandra J; Gohain S; Kapoor S; Singh P; Pemde H
Paediatr Int Child Health; 2016 Feb; 36(1):22-7. PubMed ID: 25311879
[TBL] [Abstract][Full Text] [Related]
20. Metabolic differences between short children with GH peak levels in the lower normal range and healthy children of normal height.
Tidblad A; Gustafsson J; Marcus C; Ritzén M; Ekström K
Growth Horm IGF Res; 2017 Jun; 34():22-27. PubMed ID: 28482270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
